Administrative Core
行政核心
基本信息
- 批准号:10037507
- 负责人:
- 金额:$ 16.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-14 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdministratorAdvocateBiologicalCancer BiologyCancer Center Support GrantCatchment AreaClinical SciencesCollaborationsCommunicationCommunity HealthComplexContractorDataData ProvenanceDevelopmentDiseaseDoctor of PhilosophyEnsureEnvironmental HealthEvaluationExpenditureFamily PracticeFundingFutureGoalsGrantHealthHealth systemHome environmentHuman ResourcesInfrastructureInstitutesInstitutionInstitutional support resourcesInternationalInterventionInvestmentsLeadLeadershipLife StyleMalignant NeoplasmsMedicineMonitorOccupational activity of managing financesOffice of Administrative ManagementPathologyPatientsPharmacologyPoliciesPreparationProceduresProcessProductivityProgram Research Project GrantsPublicationsRecommendationRegulationRegulatory AffairsReportingResearchResearch DesignResearch PersonnelResearch Project GrantsResource SharingResourcesScheduleScienceStrategic PlanningTherapeutic InterventionTimeTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesVertebratescancer health disparitycareerconflict resolutiondata integritydata managementexperiencehealth disparityhealth equityhuman subjectimprovedmedical schoolsmeetingsoperationprecision medicineprofessorprogramspsychosocialquality assurancesocialsuccessweb site
项目摘要
ABSTRACT – Administrative Core
The Administrative Core of the Duke Cancer Health Disparities (DCHD) P20 SPORE is responsible for
organizing and supporting two full translational research Projects; two Shared Resource Cores; a
Developmental Research Program (DRP); and a Pre-CEP (Career Enhancement Program, supported by
institutional resources), as the forerunner of our future P50 CEP. The Core is responsible for transition planning
for this DCHD P20 to compete for a full P50 SPORE grant. The Core will provide leadership, coordination,
oversight, infrastructure, and support personnel to facilitate administrative management; promote integration,
communication, and collaboration; ensure fiscal and regulatory compliance; and oversee data operations,
scientific rigor, and research progress. By serving these functions, the Core will allow investigators to focus on
conducting and disseminating translational science supported by this Program. Steven Patierno, PhD, contact
PI of this P20 SPORE, will lead this Core. Dr. Patierno will receive expert advice, assistance, and guidance
from three oversight bodies: an Executive Committee (EC) of all Project Leaders, and Core and Program
Directors, as well as Internal (IAB) and External Advisory Boards (EAB), both of which include patient
advocates. The team also benefits from an experienced Administrator, and professionals with extensive fiscal
and regulatory compliance experience. The P20 SPORE’s strong leadership and infrastructure, bolstered by
Duke’s commitment to and investment in cancer disparities research, will accelerate advancement toward our
goal of developing precision medicine interventions to mitigate cancer health disparities. The Specific Aims of
the Administrative Core are to provide administrative management and oversight (Aim 1); provide financial
management and ensure compliance with fiscal and research policies (Aim 2); provide oversight of all data
operations (Aim 3); promote integration within the P20 SPORE and the Institution (Aim 4); provide scientific
management to evaluate Program and research progress (Aim 5); and plan transition of the DCHD P20 to a
full P50 Cancer Disparities SPORE (Aim 6). The Core will monitor research progress and productivity, scientific
rigor and transparency, and effective use of Shared Resource Cores. With the EC, the Core will lead strategic
planning and implementation of activities to prepare this Program’s competitive P50 application; develop and
implement strategies to address progress, plans, challenges, and solutions, including initiation of formal
processes to replace Projects when needed; and evaluate DRP Project proposals. This Core also will connect
with quality assurance oversight provided by Duke Office of Regulatory Affairs and Quality. Finally, through
formal evaluation processes involving an external evaluation contractor, the IAB and EAB, the Core will facilitate
assessment of all activities and implement recommendations, guidance, and direction to enhance success.
摘要 – 行政核心
杜克大学癌症健康差异 (DCHD) P20 SPORE 的行政核心负责
组织和支持两个完整的转化研究项目;两个共享资源核心;
发展研究计划 (DRP);和 Pre-CEP(职业提升计划,由
机构资源),作为我们未来 P50 CEP 的先驱,核心负责过渡规划。
为了使 DCHD P20 能够竞争 P50 SPORE 的全部拨款,核心将提供领导、协调、
监督、基础设施和支持人员,以促进行政管理;
沟通和协作;确保财务和监管合规性;并监督数据运营,
通过提供这些功能,核心将使研究人员能够专注于科学研究和研究进展。
开展和传播由该计划支持的转化科学。 Steven Patierno 博士,联系人。
P20 SPORE 的 PI 将领导该核心,Patierno 博士将获得专家的建议、帮助和指导。
由三个机构监督:所有项目负责人组成的执行委员会 (EC),以及核心和计划
董事以及内部 (IAB) 和外部顾问委员会 (EAB),两者都包括患者
该团队还受益于经验丰富的管理员和拥有广泛财务的专业人士。
P20 SPORE 强大的领导力和基础设施得到了支持。
杜克大学对癌症差异研究的承诺和投资将加速我们的进步
开发精准医学干预措施以减轻癌症健康差异的目标。
行政核心提供行政管理和监督(目标 1);
管理并确保遵守财政和研究政策(目标 2);对所有数据进行监督;
运营(目标 3);促进 P20 SPORE 和机构内部的整合(目标 4);
管理层评估计划和研究进展(目标 5);并计划将 DCHD P20 过渡到
完整的 P50 癌症差异 SPORE(目标 6)将监测研究进展和生产力、科学性。
严格和透明,以及共享资源核心的有效利用,核心将在战略上发挥领导作用。
规划和实施准备该计划的竞争性 P50 应用程序的活动;
实施战略来解决进展、计划、挑战和解决方案,包括启动正式的
需要时替换项目的流程;并评估 DRP 项目提案。
最后,通过杜克大学监管事务和质量办公室提供的质量保证监督。
正式评估流程涉及外部评估承包商、IAB 和 EAB,核心将促进
评估所有活动并实施建议、指导和指导,以提高成功率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN R PATIERNO其他文献
STEVEN R PATIERNO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN R PATIERNO', 18)}}的其他基金
Duke Cancer Health Disparities P20 SPORE
杜克大学癌症健康差异 P20 SPORE
- 批准号:
10037506 - 财政年份:2020
- 资助金额:
$ 16.96万 - 项目类别:
Duke Cancer Health Disparities P20 SPORE
杜克大学癌症健康差异 P20 SPORE
- 批准号:
10263341 - 财政年份:2020
- 资助金额:
$ 16.96万 - 项目类别:
Race-related alternative splicing: novel targets in prostate cancer
种族相关的选择性剪接:前列腺癌的新靶点
- 批准号:
10153715 - 财政年份:2017
- 资助金额:
$ 16.96万 - 项目类别:
Race-related alternative splicing: novel targets in prostate cancer
种族相关的选择性剪接:前列腺癌的新靶点
- 批准号:
9925752 - 财政年份:2017
- 资助金额:
$ 16.96万 - 项目类别:
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
1/2 NCCU-DUKE 癌症差异转化研究合作伙伴关系
- 批准号:
9763335 - 财政年份:2016
- 资助金额:
$ 16.96万 - 项目类别:
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
2/2 NCCU-DUKE 癌症差异转化研究合作伙伴关系
- 批准号:
9246679 - 财政年份:2016
- 资助金额:
$ 16.96万 - 项目类别:
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
2/2 NCCU-DUKE 癌症差异转化研究合作伙伴关系
- 批准号:
9762865 - 财政年份:2016
- 资助金额:
$ 16.96万 - 项目类别:
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
2/2 NCCU-DUKE 癌症差异转化研究合作伙伴关系
- 批准号:
9353735 - 财政年份:2016
- 资助金额:
$ 16.96万 - 项目类别:
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
1/2 NCCU-DUKE 癌症差异转化研究合作伙伴关系
- 批准号:
9246378 - 财政年份:2016
- 资助金额:
$ 16.96万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Predicting firearm suicide in military veterans outside the VA health system using linked civilian electronic health record data
使用链接的民用电子健康记录数据预测退伍军人管理局卫生系统外退伍军人的枪支自杀
- 批准号:
10655968 - 财政年份:2023
- 资助金额:
$ 16.96万 - 项目类别:
Characteristics and outcomes for hospitalized patients with methamphetamine and opioid co-use: Identifying opportunities for hospital-based addiction services tailored to co-use
甲基苯丙胺和阿片类药物同时使用的住院患者的特征和结果:确定针对共同使用的医院成瘾服务的机会
- 批准号:
10677138 - 财政年份:2023
- 资助金额:
$ 16.96万 - 项目类别:
Characteristics and outcomes for hospitalized patients with methamphetamine and opioid co-use: Identifying opportunities for hospital-based addiction services tailored to co-use
甲基苯丙胺和阿片类药物同时使用的住院患者的特征和结果:确定针对共同使用的医院成瘾服务的机会
- 批准号:
10677138 - 财政年份:2023
- 资助金额:
$ 16.96万 - 项目类别:
Feasibility Trial of a Novel Integrated Mindfulness and Acupuncture Program to Improve Outcomes after Spine Surgery (I-MASS)
旨在改善脊柱手术后效果的新型综合正念和针灸计划的可行性试验(I-MASS)
- 批准号:
10649741 - 财政年份:2023
- 资助金额:
$ 16.96万 - 项目类别:
Impact of the MISSION Act on Quality and Outcomes of Interventional Cardiology and Cardiac Surgery among Veterans
《使命法案》对退伍军人介入心脏病学和心脏手术的质量和结果的影响
- 批准号:
10640085 - 财政年份:2022
- 资助金额:
$ 16.96万 - 项目类别: